Taro Pharmaceutical GAAP EPS of $0.70 misses by $0.21, revenue of $138.98M misses by $3.24M
Taro Pharmaceutical press release (NYSE:TARO): FQ3 GAAP EPS of $0.70 misses by $0.21. Revenue of $138.98M (-0.8% Y/Y) misses by $3.24M.
Seekingalpha · 1小时前
Taro Pharmaceutical Indus Q3 EPS $0.70 Down From $0.86 YoY, Sales $139.00M Miss $142.22M Estimate
Taro Pharmaceutical Indus (NYSE:TARO) reported quarterly earnings of $0.70 per share. This is a 18.6 percent decrease over earnings of $0.86 per share from the same period last year. The company reported quarterly sales
The Daily Biotech Pulse: Galapagos Appoints J&J Exec As CEO, Aridis Gets Funding For Antiviral Treatment, Moderna Starts Omicron-Specific Booster Study
Here's a roundup of top developments in the biotech space over the last 24 hours:
Benzinga · 10小时前
Taro Pharmaceutical Q3 2022 Earnings Preview
Taro Pharmaceutical (NYSE:TARO) is scheduled to announce Q3 earnings results on Thursday, January 27th, after market close. The consensus EPS Estimate is $0.91 (+37.9% Y/Y) and the consensus Revenue Estimate
Is The Market Rewarding Taro Pharmaceutical Industries Ltd. (NYSE:TARO) With A Negative Sentiment As A Result Of Its Mixed Fundamentals?
It is hard to get excited after looking at Taro Pharmaceutical Industries' (NYSE:TARO) recent performance, when its...
Simply Wall St. · 2天前
Taro to Announce Third Quarter Results on January 27, 2022
HAWTHORNE, N.Y., January 21, 2022--Taro to Announce Third Quarter Results on January 27, 2022
Business Wire · 6天前
芋头制药 (TARO) 收益有望增长：您应该购买吗？
Taro (TARO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks · 01/19 20:01
Taro (TARO) Surges 6.6%: Is This an Indication of Further Gains?
Taro (TARO) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Zacks · 01/05 12:48
Hot Stocks: AAPL touches $3T; retailers rally; GILT soars; TARO sets low; APLT drops on delayed application
The same optimistic view that fueled 2021's 27% advance in the S&P 500 carried over into the new year. With investor sentiment remaining strong, the major averages scored modest gains
Seekingalpha · 01/03 22:52
年初至今下跌超过 20%，抓住这 3 只买入评级的医疗保健股，争取 2022 年反弹
StockNews.com · 01/02 00:13
Down More Than 20% YTD, Grab These 3 Buy-Rated Healthcare Stocks for a 2022 Rebound
StockNews.com · 2021/12/27 15:22
The Daily Biotech Pulse: Moderna, Pfizer-BioNTech Ink New Vaccine Deals With UK, GSK-Vir Antibody Show Activity Against Omicron, Chemomab Gets Clearance
Here's a roundup of top developments in the biotech space over the last 24 hours.
Benzinga · 2021/12/02 12:51
Taro Pharmaceutical Industries (NYSE:TARO) appoints William J. Coote as Vice President, CFO and Chief Accounting Officer, effective today. Most recently, Mr. Coote has held progressively responsible positions with a variety of global companies
Seekingalpha · 2021/12/01 22:42
Raging Capital Management, an investment management firm, published its third-quarter 2021 investor letter – a copy of which can be downloaded here. The fund has compounded its returns at double-digits annually since its inception in 2006, but it plainly d...
Insider Monkey · 2021/11/15 17:15
Taro Pharmaceutical EPS misses by $0.36, misses on revenue
Taro Pharmaceutical (NYSE:TARO): Q3 GAAP EPS of $0.66 misses by $0.36. Revenue of $132M (-7.6% Y/Y) misses by $21.23M. Press Release
Seekingalpha · 2021/10/28 21:32
BRIEF-Taro Pharmaceutical Industries Reports Qtrly Sales Of $132 Million
reuters.com · 2021/10/28 21:17
Taro Pharmaceutical (TARO) Lags Q2 Earnings and Revenue Estimates